Cancer treatment has made significant advances through the years. Once dominated by chemotherapy agents, targeted therapy is now a better option, with less-taxing adverse effects (AEs). Chemotherapy agents, such as alkylating agents, antimetabolites, and plant alkaloids affect dividing cells, both cancerous and noncancerous. This leads to many AEs, such as hair loss, diarrhea, and vomiting. Conversely, targeted therapy is designed to reach cancer cells only, using molecular targets such as kinases or growth factors. With this approach, there are fewer AEs, and this results in better tolerability and continuance of therapy. However, it is impossible to assert that patients will not experience any AEs while on targeted therapy. Communicating and addressing effective mitigation strategies to ameliorate these AEs can lead to improved clinical outcomes.
Acneiform Rash One unique toxicity associated with tyrosine kinase inhibitors (TKIs), which target the epidermal growth factor receptor (EGFR), is a rash. Because the EGFR is present in epithelial cells lining the skin, inhibiting it with certain TKIs, such as erlotinib and gefitinib, can produce acneiform rash.1 The same is true for mitogen-activated protein kinase inhibitors (MEKIs), such as trametinib. Importantly, clinicians should note that in patients taking MEKIs, the rash presents as papules and pustules on the front torso and the face at a higher incidence than with traditional chemotherapy.1,2 Prophylactic treatment modalities for rash include corticosteroids, moisturizers, and sunscreen. Other therapies include dapsone gel and oral doxycycline. When a bacterial skin infection is suspected, clinicians should initiate antibiotics.2
Hypertension Angiogenesis is a pathway for cancers to grow with the vascular endothelial growth factor (VEGF). Several TKIs target the VEGF pathway, including sunitinib, sorafenib, and cabozantinib.3 These therapies are used in the first line in metastatic renal cell carcinoma and have been associated with hypertension. This is primarily due to impaired nitric oxide signaling and reduced prostacyclin production when VEGF is inhibited.3 The treatment for VEGF-induced hypertension is combination therapy consisting of angiotensin-converting enzyme inhibitors and dihydropyridine calcium channel blockers.3 In more severe cases, dose reduction of therapy may be warranted.
Stomatitis Stomatitis is a very painful AE characterized by ulcers around the mucosa of the mouth, making swallowing difficult. The agents that cause most cases of stomatitis are the mammalian target of rapamycin (mTOR) inhibitors. Everolimus, temsirolimus, and sirolimus are linked to the development of stomatitis in 30% of patients.2 The SWISH trial results showed that after 8 weeks of treatment, the incidence of stomatitis was reduced to 2% among those who used a steroid mouthwash.2,4 Clinicians should educate patients on proper hygiene, such as washing their mouth with sterile water or sodium bicarbonate. For patients who are about to start therapy with everolimus, the initiation of a dexamethasone-based mouthwash has shown promising results.4 Multikinase inhibitors and EGFR inhibitors can also cause stomatitis, although it gradually disappears over time.2
Alopecia Hair loss, or alopecia, has been reported in more than half of patients who have breast cancer. This AE is associated primarily with hormone therapy, especially selective estrogen receptor modulators, which accounted for 25% of cases.2 Inhibiting estrogen production is associated with a decrease in hair follicles, causing hair to become brittle and break easily. One way to reduce this AE is to apply topical minoxidil, which has shown efficacy in 80% of treated patients.2
Nail Toxicities Both chemotherapy and targeted agents are associated with nail toxicities. Paronychia is a type of skin infection surrounding the toenail or fingernail and is characterized by inflammation, swelling, and general discomfort. A complication of paronychia is periungual granulomas, which are vascular tumors of the capillaries.2 The development of lesions is also common and can lead to brittle nails and onycholysis. Many targeted therapies, such as EGFR, MEK, and mTOR inhibitors, are associated with these nail toxicities.2 Preventive strategies include educating patients to avoid friction, wearing gloves or socks to protect the nails, and limiting pressure on the nails. Treatments include topical corticosteroids, antibiotics, and silver nitrate. Topical timolol has also been effective in periungual granulomas.2
Thyroid Disorders Hypothyroidism is more common than hyperthyroidism. TKIs are associated mainly with hypothyroidism as they change the blood flow to the thyroid, which causes destructive thyroiditis. Many of the symptoms can be confused with the symptoms of the cancer5; these include, fatigue, constipation, muscle weakness, and thinning of hair. Clinicians should monitor the thyroid stimulating hormone (TSH) levels of patients who are not on thyroid replacement therapy. Treatment with replacement therapy is warranted in patients who are symptomatic and have severe hypothyroidism. For patients on levothyroxine who are starting imatinib, sorafenib, or sunitinib, TSH monitoring every 4 weeks is recommended.
Dyslipidemia Dyslipidemia is an often-overlooked AE in cancer therapy that sometimes leads to cardiovascular complications. The prevalence of dyslipidemia from using mTOR inhibitors is as high as 81% because they impair lipid clearance from the bloodstream.5 Clinicians should obtain a lipid profile before the start of an mTOR inhibitor and repeat it every 6 weeks while the patient is on treatment. Although grade 1 and 2 toxicities do not require any interventions, grade 3 toxicity requires interruption of therapy and restarting the mTOR inhibitor at 50% of the dose.5 Discontinue therapy if grade 4 toxicity occurs. Importantly, patients with elevated cholesterol should start treatment with lipid-lowering agents. However, please note that cytochrome P450 3A4substrate statinssimvastatin and atorvastatinare associated with drug interactions that must be evaluated prior to first use.6
Glucose-Related Disorders The disruption of glucose metabolism has been associated with several targeted therapies. Hyperglycemia is associated with phosphoinositide 3-kinases, AKT, and mTOR inhibitors, as they help to regulate insulin signaling.5 Common symptoms of hyperglycemia include polyuria, polydipsia, and fatigue. Clinicians must monitor patients for their fasting serum glucose prior to therapy initiation and ensure they achieve optimal glycemic control. Treatment should be initiated with antidiabetic agents for grade 2 hyperglycemia, and treatment should be interrupted or discontinued for grades 3 and 4.5 In the case of hypoglycemia, TKIsparticularly imatinib, dasatinib, sorafenib, and sunitinibhave been shown to decrease glucose levels. Notably, sunitinib and pazopanib have induced hypoglycemia in patients on antidiabetic agents.5 Patients on targeted therapy must maintain glycemic control and understand the risks of severe hypoglycemia.
Electrolyte Disorders Many targeted therapies are associated with electrolyte imbalances (Table 5), so it is important to monitor electrolyte levels throughout therapy. For these disorders, treatment is primarily symptomatic management without interruption of the oncology agent. Most attributable agents associated with electrolyte disorders are TKIs and mTOR inhibitors. A bimonthly chemistry profile should be initiated in the first 3 months of treatment and then repeated monthly thereafter.5
Table: Electrolyte Disorders with Targeted Therapies5
Every patient will experience AEs differently while on oral targeted therapy. Many of the AEs previously mentioned are unique to certain classes of medications. Informing patients of the mitigation strategies prior to therapy will help reduce the risk of complications. Additionally, health care professionals and patients should recognize, monitor, and communicate AEs so they can be resolved in a timely manner.
Here is the original post:
Management of Targeted Therapy Adverse Effects - Pharmacy Times
- Hypertension: Practice Essentials, Background, Pathophysiology - Medscape Reference - April 10th, 2018 [April 10th, 2018]
- High blood pressure (hypertension) - Symptoms and causes ... - May 18th, 2018 [May 18th, 2018]
- 10 Causes of Hypertension - A Diet High In Salt Content - June 21st, 2018 [June 21st, 2018]
- Homeopathy Hypertension Remedies | High Blood Pressure ... - July 5th, 2018 [July 5th, 2018]
- European Society of Hypertension - July 7th, 2018 [July 7th, 2018]
- List of High Blood Pressure (Hypertension) Medications (259 ... - July 26th, 2018 [July 26th, 2018]
- Hypertension (High Blood Pressure) Charts, Symptoms, Diet ... - September 2nd, 2018 [September 2nd, 2018]
- Vitamin D and hypertension - September 8th, 2018 [September 8th, 2018]
- 2014 Guideline for Management of High Blood Pressure - September 29th, 2018 [September 29th, 2018]
- Essential hypertension - Wikipedia - September 30th, 2018 [September 30th, 2018]
- Hypertension Treatment & Drugs | Hypertension Causes ... - September 30th, 2018 [September 30th, 2018]
- Hypertension (High Blood Pressure) - October 13th, 2018 [October 13th, 2018]
- Hypotension - Wikipedia - October 30th, 2018 [October 30th, 2018]
- Hypertension | pathology | Britannica.com - October 30th, 2018 [October 30th, 2018]
- Hypertension | Cornell University College of Veterinary Medicine - November 10th, 2018 [November 10th, 2018]
- 2014 Guideline for Management of High Blood Pressure - JAMA - November 18th, 2018 [November 18th, 2018]
- Pharmacologic Treatment of Hypertension in Adults | Annals ... - November 18th, 2018 [November 18th, 2018]
- 10 Causes of Hypertension - High In Salt Consumption - November 29th, 2018 [November 29th, 2018]
- High blood pressure (hypertension) - Diagnosis and treatment ... - November 29th, 2018 [November 29th, 2018]
- High Blood Pressure Symptoms - Hypertension Symptoms - December 9th, 2018 [December 9th, 2018]
- Hypertension - Medscape Reference - December 21st, 2018 [December 21st, 2018]
- Hypertension - Lab Tests Online - December 21st, 2018 [December 21st, 2018]
- High Blood Pressure (Hypertension): Symptoms ... - OnHealth - December 21st, 2018 [December 21st, 2018]
- High Blood Pressure | Hypertension | MedlinePlus - December 27th, 2018 [December 27th, 2018]
- Hypertension - Wikipedia - December 27th, 2018 [December 27th, 2018]
- Hypertension: Causes and Risk Factors - verywellhealth.com - January 1st, 2019 [January 1st, 2019]
- Hypertension - Genetics Home Reference - NIH - January 20th, 2019 [January 20th, 2019]
- Hypertension: Nursing Care Management and Study Guide - April 7th, 2019 [April 7th, 2019]
- High blood pressure (hypertension) Disease Reference Guide ... - April 7th, 2019 [April 7th, 2019]
- Pulmonary hypertension - Symptoms and causes - Mayo Clinic - September 14th, 2019 [September 14th, 2019]
- Incident Hypertension Associated With Continuous NSAID Use in Ankylosing Spondylitis - Rheumatology Advisor - October 12th, 2019 [October 12th, 2019]
- The innovative new ways scientists are tackling high blood pressure - Noted - October 12th, 2019 [October 12th, 2019]
- If You Have High Blood Pressure, You May Be at Higher Risk for This Cancer - msnNOW - October 12th, 2019 [October 12th, 2019]
- MODERATO II Study: Cardiac Neuromodulation Significantly Reduces Systolic Blood Pressure - Diagnostic and Interventional Cardiology - October 12th, 2019 [October 12th, 2019]
- Kidney-heart connection is focus of upcoming HealthyLife seminar - Times Union - October 12th, 2019 [October 12th, 2019]
- High blood pressure: Six foods proven to lower your reading - Express - October 14th, 2019 [October 14th, 2019]
- Sepetaprost Effective and Safe in Glaucoma, Ocular Hypertension - Monthly Prescribing Reference - October 14th, 2019 [October 14th, 2019]
- India, Stressed: More than Half of Commuters in Metro Cities Likely to Commit Road Rage - News18 - October 17th, 2019 [October 17th, 2019]
- University College London Awarded 1M to Advance Heart, PH Research Using Computational Biology - Pulmonary Hypertension News - October 17th, 2019 [October 17th, 2019]
- One in 10 children on the verge of heart attack risk - The New Daily - October 17th, 2019 [October 17th, 2019]
- Healthy living: Salt and hypertension - Forbes India - October 17th, 2019 [October 17th, 2019]
- The global blood pressure (BP) monitoring devices market size is expected to reach USD 2.47 billion by 2026 - GlobeNewswire - October 17th, 2019 [October 17th, 2019]
- Vitamin D Deficiency And Hypertension: Is There A Relation Between Low Levels Of Vitamin D And High Blood Pressure? - NDTV News - October 17th, 2019 [October 17th, 2019]
- Hypertension in Indians - Forbes India - October 17th, 2019 [October 17th, 2019]
- Health: Worrying rise of hypertension in Indians - Forbes India - October 17th, 2019 [October 17th, 2019]
- More than 1100 health care organizations earn BP-control honor - American Medical Association - October 17th, 2019 [October 17th, 2019]
- Medication Adherence In Patients With Arterial Hypertension: The Relat | PPA - Dove Medical Press - October 17th, 2019 [October 17th, 2019]
- High levels of stress increase hypertension risk in black individuals - Healio - October 17th, 2019 [October 17th, 2019]
- Dapagliflozin Receives FDA Approval for Reducing Heart Failure Hospitalization Risk - Endocrinology Advisor - October 23rd, 2019 [October 23rd, 2019]
- Death of Clay County inmate prompts change in housing for inmates with specific medical needs - FirstCoastNews.com WTLV-WJXX - October 23rd, 2019 [October 23rd, 2019]
- New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical and Functional Parameters in Patients with... - October 23rd, 2019 [October 23rd, 2019]
- High Blood Pressure: Why salt is considered a harbinger of hypertension? - PINKVILLA - October 23rd, 2019 [October 23rd, 2019]
- Chronic Stress in African-Americans Linked to Hypertension - TCTMD - October 23rd, 2019 [October 23rd, 2019]
- Why all the fuss around hypertension? - Firstpost - October 23rd, 2019 [October 23rd, 2019]
- Study explores why Caribbean adults have higher hypertension rates - Yale News - October 23rd, 2019 [October 23rd, 2019]
- Hypertension in adults: summary of updated NICE guidance - The BMJ - October 23rd, 2019 [October 23rd, 2019]
- Diabetes, blood pressure and cancer cases are rising rapidly in India - Times of India - November 2nd, 2019 [November 2nd, 2019]
- Is there a link between breastfeeding and diabetes - Medical News Bulletin - November 2nd, 2019 [November 2nd, 2019]
- High Blood Pressure: Lower hypertension by eating less of these food groups - PINKVILLA - November 2nd, 2019 [November 2nd, 2019]
- Chronic high blood pressure in pregnant women on the rise - MahoningMatters.com - November 2nd, 2019 [November 2nd, 2019]
- Unhealthy Lifestyle and Indian Ethnicity Tied to Hypertension - Forbes India - November 2nd, 2019 [November 2nd, 2019]
- Cardio Round-up: Walkability and CVD; Pollution and Stroke; and More - DocWire News - November 2nd, 2019 [November 2nd, 2019]
- Hypertension Tied to Over One-Third of Population-Attributable CVD Risk in U.S. Black Adults - DocWire News - November 2nd, 2019 [November 2nd, 2019]
- This Is What Makes Oats Idli An Ideal Breakfast For A High Blood Pressure Diet - NDTV Food - November 11th, 2019 [November 11th, 2019]
- Global Idiopathic Intracranial Hypertension Therapeutics Market 2019-2023 | Evolving Opportunities with AbbVie Inc. and Astellas Pharma Inc. |... - November 11th, 2019 [November 11th, 2019]
- Severe Hypertension Common in aHUS Patients and Soliris Effective at Treating Them, Study Finds - aHUS News - November 11th, 2019 [November 11th, 2019]
- Overhydration Is a Risk Factor for Post-Dialysis Hypertension - Renal and Urology News - November 11th, 2019 [November 11th, 2019]
- In AS, Hypertension Risk Linked to Continuous NSAID Use, Study Says - Ankylosing Spondylitis News - November 11th, 2019 [November 11th, 2019]
- Physicians, Patient Discuss Intentional Nonadherence in Hypertension Therapy - AJMC.com Managed Markets Network - November 11th, 2019 [November 11th, 2019]
- More than 50,000 suffer from diabetes, nearly a lakh from hypertension - The Indian Express - November 14th, 2019 [November 14th, 2019]
- Cause of John Witherspoons untimely death revealed - TheGrio - November 14th, 2019 [November 14th, 2019]
- This Hyderabad-based Start-up is Helping Corporates Improve the Health of their Employees - Entrepreneur - November 14th, 2019 [November 14th, 2019]
- ER visits jumped after valsartan blood pressure medication recall, study says - CBC.ca - November 14th, 2019 [November 14th, 2019]
- The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension - Science - November 14th, 2019 [November 14th, 2019]
- Health screenings given to raise awareness at West Philly barbershop - The Philadelphia Tribune - November 14th, 2019 [November 14th, 2019]
- Blood pressure monitoring must be a part of a diabetic's routine - Gulf News - November 14th, 2019 [November 14th, 2019]
- Early Warning Signs of CKD Going Unnoticed in Veterans, Especially Those With Hypertension - AJMC.com Managed Markets Network - November 14th, 2019 [November 14th, 2019]
- The Epidemic of Hypertension and Vulnerability of Indians - Forbes India - November 14th, 2019 [November 14th, 2019]
- Knowing the facts: Hypertension vis-a-vis Lifestyle - Forbes India - November 14th, 2019 [November 14th, 2019]
- Heart hormones that affect development of diabetes, hypertension differ in African Americans and whites - UAB News - November 14th, 2019 [November 14th, 2019]